perfluorooctane sulfonic acid has been researched along with Chemical and Drug Induced Liver Injury in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 7 (43.75) | 2.80 |
| Authors | Studies |
|---|---|
| Billy, LJ; Chang, S; Gonzalez, FJ; Patterson, AD; Peters, JM; Su, S | 1 |
| Dai, J; Guo, H; Guo, Y; Sheng, N; Wang, Z; Yao, J | 1 |
| Chen, J; Lin, H; Liu, F; Liu, Z; Shen, L; Wu, H; Yang, H; Zhang, H; Zhang, X; Zhong, Y | 1 |
| Dai, J; Guo, H; Guo, Y; Ren, W; Sheng, N; Wang, Z; Zang, L; Zhou, X | 1 |
| An, H; Ao, L; Cao, J; Chen, Q; Cui, H; He, S; Ling, X; Liu, J; Wang, L; Yang, W; Yang, Z; Zou, P | 1 |
| Li, S; Luo, D; Xu, S; Yin, H; Zhang, J | 1 |
| Deng, P; Hennig, B; Morris, AJ; Sexton, T; Wahlang, B; Wang, C | 1 |
| Cui, Q; Cui, R; Dai, J; Guo, H; Guo, Y; Sheng, N; Sun, Y; Zhang, H; Zhou, X | 1 |
| Ge, S; Jia, R; Kuang, H; Lin, T; Lv, Z; Wei, J; Wu, L; Wu, W; Yang, B; Yuan, Y; Zhang, D | 1 |
| Liang, X; Su, M; Wu, X; Xu, X; Yang, B | 1 |
| Cui, Q; Dai, J; Guo, H; Guo, Y; Pan, Y; Sheng, N; Shi, G; Wang, J | 1 |
| Ding, W; Han, R; Li, F; Liu, L; Wan, C; Xiang, M; Zhang, F | 1 |
| Dai, J; Guo, X; Guo, Y; Pan, Y; Sheng, N; Sun, Y; Zheng, F; Zhou, X | 1 |
| Billah, MB; Chan, TF; Cheung, A; Lai, KP; Li, JW; Li, R; Wong, CKC | 1 |
| Butenhoff, JL; Chang, S; Olsen, GW | 1 |
| Abedi-Valugerdi, M; DePierre, JW; Hassan, M; Nelson, BD; Qazi, MR | 1 |
16 other study(ies) available for perfluorooctane sulfonic acid and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
Topics: Acyl-CoA Oxidase; Alkanesulfonic Acids; Animals; Aryl Hydrocarbon Hydroxylases; Chemical and Drug Induced Liver Injury; Constitutive Androstane Receptor; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Dose-Response Relationship, Drug; Environmental Pollutants; Fluorocarbons; Humans; Liver; Male; Mice, 129 Strain; Mice, Knockout; PPAR alpha; Pregnane X Receptor; Signal Transduction; Species Specificity; Steroid Hydroxylases | 2022 |
Comparative Hepatotoxicity of a Novel Perfluoroalkyl Ether Sulfonic Acid, Nafion Byproduct 2 (H-PFMO2OSA), and Legacy Perfluorooctane Sulfonate (PFOS) in Adult Male Mice.
Topics: Alkanesulfonic Acids; Animals; Chemical and Drug Induced Liver Injury; Ether; Ethers; Fluorocarbon Polymers; Fluorocarbons; Liver; Male; Mice; Sulfonic Acids | 2022 |
Assessing the hepatotoxicity of PFOA, PFOS, and 6:2 Cl-PFESA in black-spotted frogs (Rana nigromaculata) and elucidating potential association with gut microbiota.
Topics: Alanine Transaminase; Alkanesulfonic Acids; Animals; Caprylates; Catalase; Chemical and Drug Induced Liver Injury; Ethers; Fluorocarbons; Gastrointestinal Microbiome; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Male; Malondialdehyde; Mitogen-Activated Protein Kinases; Molecular Docking Simulation; NF-E2-Related Factor 2; Ranidae | 2022 |
Bile acid metabolism disorder mediates hepatotoxicity of Nafion by-product 2 and perfluorooctane sulfonate in male PPARα-KO mice.
Topics: Alkanesulfonic Acids; Animals; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Fluorocarbons; Liver; Male; Mice; PPAR alpha | 2023 |
PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
Topics: Alkanesulfonic Acids; Animals; Caprylates; Chemical and Drug Induced Liver Injury; Cross-Sectional Studies; Environmental Pollutants; Fluorocarbons; Humans; Lipid Metabolism; Lipid Metabolism Disorders; Mice; Non-alcoholic Fatty Liver Disease; Nutrition Surveys; PPAR alpha; Rats | 2023 |
Cannabidiol alleviates perfluorooctane sulfonate-induced macrophage extracellular trap mediate inflammation and fibrosis in mice liver.
Topics: Animals; Cannabidiol; Chemical and Drug Induced Liver Injury; Extracellular Traps; Fibrosis; Inflammation; Macrophages; Mice; NF-kappa B | 2023 |
Co-exposure to PCB126 and PFOS increases biomarkers associated with cardiovascular disease risk and liver injury in mice.
Topics: Alkanesulfonic Acids; Animals; Biomarkers; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Environmental Pollutants; Fibrosis; Fluorocarbons; Liver; Male; Mice; Mice, Inbred C57BL; Polychlorinated Biphenyls; Risk; Thrombosis | 2020 |
Subchronic Hepatotoxicity Effects of 6:2 Chlorinated Polyfluorinated Ether Sulfonate (6:2 Cl-PFESA), a Novel Perfluorooctanesulfonate (PFOS) Alternative, on Adult Male Mice.
Topics: Alkanesulfonic Acids; Animals; Chemical and Drug Induced Liver Injury; Ether; Ethers; Fluorocarbons; Liver; Male; Mice | 2018 |
Naringin protects against perfluorooctane sulfonate-induced liver injury by modulating NRF2 and NF-κB in mice.
Topics: Alkanesulfonic Acids; Animals; Chemical and Drug Induced Liver Injury; Flavanones; Fluorocarbons; Gene Expression Regulation; Liver; Male; Mice; NF-E2-Related Factor 2; NF-kappa B; Protective Agents; Up-Regulation | 2018 |
Hepatoprotective benefits of vitamin C against perfluorooctane sulfonate-induced liver damage in mice through suppressing inflammatory reaction and ER stress.
Topics: Alkanesulfonic Acids; Animals; Anti-Inflammatory Agents; Ascorbic Acid; Chemical and Drug Induced Liver Injury; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Fluorocarbons; Male; Mice, Inbred ICR; Protective Agents; Vitamins | 2019 |
Chronic exposure to 6:2 chlorinated polyfluorinated ether sulfonate acid (F-53B) induced hepatotoxic effects in adult zebrafish and disrupted the PPAR signaling pathway in their offspring.
Topics: Alkanesulfonates; Alkanesulfonic Acids; Animals; Chemical and Drug Induced Liver Injury; Female; Fluorocarbons; Gonads; Halogenation; Hepatomegaly; Humans; Larva; Lipid Metabolism; Liver; Male; Peroxisome Proliferator-Activated Receptors; Signal Transduction; Triglycerides; Water Pollutants, Chemical; Zebrafish | 2019 |
Role of miR-155 in fluorooctane sulfonate-induced oxidative hepatic damage via the Nrf2-dependent pathway.
Topics: Actin Cytoskeleton; Alanine Transaminase; Alkanesulfonic Acids; Animals; Apoptosis; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Endothelial Cells; Fluorocarbons; Hep G2 Cells; Humans; Male; MicroRNAs; NF-E2-Related Factor 2; Organ Size; Rats, Sprague-Dawley; Reactive Oxygen Species | 2016 |
Comparative hepatotoxicity of 6:2 fluorotelomer carboxylic acid and 6:2 fluorotelomer sulfonic acid, two fluorinated alternatives to long-chain perfluoroalkyl acids, on adult male mice.
Topics: Alkanesulfonic Acids; Animals; Caprylates; Carboxylic Acids; Chemical and Drug Induced Liver Injury; Fluorocarbons; Lipid Metabolism; Liver; Male; Mice; Organ Size; PPAR alpha; PPAR gamma; Sulfonic Acids | 2017 |
Transcriptome sequencing reveals prenatal PFOS exposure on liver disorders.
Topics: Alkanesulfonic Acids; Animals; Cell Transformation, Neoplastic; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Environmental Pollutants; Fatty Acids; Female; Fetal Diseases; Fluorocarbons; Lipid Metabolism; Male; Mice; Neoplasms; Pregnancy; Prenatal Exposure Delayed Effects; Transcriptome | 2017 |
Toxicological response of Sprague Dawley rats from inhalation exposure to perfluorooctane sulfonyl fluoride (POSF).
Topics: Alkanesulfonic Acids; Animals; Chemical and Drug Induced Liver Injury; Cholesterol; Eating; Environmental Pollutants; Female; Fluorocarbons; Hydrofluoric Acid; Hydrolysis; Hypertrophy; Inhalation Exposure; Laryngeal Cartilages; Liver; Lung; Macrophages, Alveolar; Male; Necrosis; Organ Size; Rats, Sprague-Dawley; Risk Assessment; Time Factors; Toxicity Tests; Weight Gain | 2017 |
Both sub-acute, moderate-dose and short-term, low-dose dietary exposure of mice to perfluorooctane sulfonate exacerbates concanavalin A-induced hepatitis.
Topics: Alkanesulfonic Acids; Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytokines; Disease Models, Animal; Disease Progression; DNA Fragmentation; Dose-Response Relationship, Drug; Environmental Pollutants; Fluorocarbons; Hepatomegaly; Immunologic Factors; Liver; Male; Mice; Mice, Inbred C57BL; Random Allocation; Time Factors; Transaminases | 2013 |